Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2014

01-02-2014 | Letter to the Editor

Membranoproliferative glomerulonephritis associated with IgA-λ monoclonal gammopathy

Authors: Boting Wu, Pu Chen, Weiguang Wang, Feng Li, Shanhua Zou, Yunfeng Cheng

Published in: Annals of Hematology | Issue 2/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Leung N, Gertz MA (2012) The spectrum of monoclonal gammopathies affecting the kidney. Leuk Lymphoma 53(9):1656–1657PubMedCrossRef
2.
Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand J-P, Dispenzieri A, Song KW, Kyle RA (2012) Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined of insignificant. Blood 120(22):4292–4295PubMedCrossRef
3.
Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D’Agati VD (2004) Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 65(1):85–96PubMedCrossRef
4.
Soares SM, Lager DJ, Leung N, Haugen EN, Fervenza FC (2006) A proliferative glomerulonephritis secondary to a monoclonal IgA. Am J Kidney Dis 47(2):342–349PubMedCrossRef
5.
Komatsuda A, Nara M, Ohtani H, Nimura T, Sawada K, Wakui H (2012) Proliferative glomerulonephritis with monoclonal immunoglobulin light chain deposits: a rare entity mimicking immune-complex glomerulonephritis. Intern Med 51(23):3273–3276PubMedCrossRef
6.
Sethi S, Zand L, Leung N, Smith RJH, Jevremonic D, Herrmann SS, Fervenza FC (2010) Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 5(5):770–782PubMedCrossRef
Metadata
Title
Membranoproliferative glomerulonephritis associated with IgA-λ monoclonal gammopathy
Authors
Boting Wu
Pu Chen
Weiguang Wang
Feng Li
Shanhua Zou
Yunfeng Cheng
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1809-y

Other articles of this Issue 2/2014

Annals of Hematology 2/2014 Go to the issue

Letter to the Editor

Imaging studies in extramedullary hematopoiesis of the spleen

Original Article

Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1

Letter to the Editor

Azathioprine-associated pure red cell aplasia in renal transplant recipients: a report of two cases

Original Article

Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response

Letter to the Editor

Lenalidomide monotherapy in relapsed primary cutaneous diffuse large B cell lymphoma-leg type

Review Article

Progress in detecting cell-surface protein receptors: the erythropoietin receptor example
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits